To contact FractalMed, please fill in this form and we will respond as soon as possible.

FractalMed clinical applications areas

Fractal dimension brain analysis has enable to show the differences between healthy people’s brain and patients with neurological diseases, such as:

  • Multiple Sclerosis
  • Ictus
  • Neurodegenerative diseases
  • Dementia
  • Brain tumors
  • Intrauterine growth delay
  • Brain malformation
In the case of Multiple Sclerosis, we have observed that fractal dimension has enable us to distinguish between phenotypes and subtypes of the disease (in form of outbreaks or progressives), as well as that it is related to patient’s disability.

Therefore, Fractalmed® analysis is highly useful to support the diagnosis of the disease and likely to monitor the development of it.

Nowadays, we are assessing the capacity of Fractalmed to be used as a prognosis biomarker or predictive biomarker de respuesta al tratamiento, lo que permitirá ayudar en la toma de desiciones clínicas respecto al manejo de la enfermedad.

To this effect, Fractalmed® will request the CE marking in order to be used in support of clinical diagnosis.

FractalMed main clinical application areas:
Detection of Multiple Sclerosis
Detection of brain disorder in brain resonance imaging in normal appearing

Clinically isolated syndrome patients type show changes on the FD of the white and grey matter in normal appearing before damages appear.

Detection of Neurological Diseases
Detection of brain disorders in other neurological diseases with resonance imaging in normal appearing

Some changes have been detected in the brain FD imaging of patients with other neurological diseases, such as Schizophrenia, Alzheimer and Parkinson amongst others.

Monitoring of Multiple Sclerosis
Monitoring the development of Multiple Sclerosis

FD varies significantly depending on the type of MS, so it allows for parametrization of the monitoring, and therefore the tracking of the disease.

Detection of brain changes
Detection of changes in normal brain aging

A change in the FD of brain structures while using resonance imaging of normal individuals during their aging has also been revealed.

Detection of brain disorder in prematures
Detection of brain disorders in premature infants

We have obtained results regarding detection of brain disorder in premature infants who suffered intrauterine growth restriction and premature birth even when the brain imaging was appearing normal.

Monitoring of brain tumors
Monitoring the evolution of brain tumors

It has been found that the FD allows the monitoring of neuroradiological brain tumors with antiangiogenic treatments.

Software

Benefits of FractalMed

Fractal dimension brain analysis has enable to show the differences between healthy people’s brain and patients with neurological diseases, such as:

  • 1. Rapidity in the diagnosis of neurological diseases
  • 2. Increasing the reliability, robustness and accuracy of the diagnosis
  • 3. Improving the personalization of the medical treatment
  • 4. Improving patients´ quality of life.
At present, FractalMed FractalMed is in the international multicentric pre-regulatory validation phase, which is endorsed by an international scientific panel.